Neuropad for detecting preclinical diabetic peripheral neuropathy: Medical technologies guidance [MTG38] – NICE

The case for adopting Neuropad to detect preclinical diabetic peripheral neuropathy is not supported by the evidence. Neuropad detects sub-normal sweating in patients with diabetes but the clinical importance of this in current NHS care pathways is poorly defined. There

The Vest for delivering high-frequency chest wall oscillation in people with complex neurological needs: Medtech innovation briefing [MIB159] – NICE

The technology described in this briefing is The Vest. It is intended to deliver high-frequency chest wall oscillation for clearing airways. The focus of this briefing is its use in adults and children with complex neurological needs, such as cerebral palsy and

Children with long-term conditions in the North West: Emergency hospital admissions for asthma, diabetes and epilepsy 2008/09 – Liverpool John Moores University Centre for Public Health

The North West has the highest child emergency hospital admission rate for both asthma and epilepsy and the second highest admission rate for diabetes in England. This report details child emergency hospital admission rates, emergency bed day rates and average

Lutetium (177Lu) oxodotreotide for treating unresectable or metastatic neuroendocrine tumours: Technology appraisal guidance [TA539] – NICE

Evidence-based recommendations on lutetium (177Lu) oxodotreotide (Lutathera) for treating unresectable or metastatic neuroendocrine tumours in adults. Lutetium (177Lu) oxodotreotide is recommended, within its marketing authorisation, as an option for treating unresectable or metastatic, progressive, well-differentiated (grade 1 or grade 2), somatostatin receptor-positive

A Health Needs Assessment for Children and Adults with Neurodevelopmental Conditions in Liverpool – Liverpool John Moores University Public Health Institute

A rapid health needs assessment for children and adults with neurodevelopmental conditions including attention deficit hyperactivity disorder (ADHD) and autistic spectrum disorder (ASD). This report includes a review of the literature which details: risk factors, prevalence estimates and a summary

CPG Hospices and Palliative Care: Inquiry Inequalities in access to hospice and palliative care – Cross Party Group Hospices and Palliative Care

Welsh Assembly Cross Party Group Hospices and Palliative Care report finding people with terminal illnesses and life-limiting conditions in Wales – especially dementia, heart failure and neurological conditions – face a range of barriers in accessing hospice and palliative care. 

Brain tumours (primary) and brain metastases in adults: NICE guideline [NG99] – NICE

This guideline covers diagnosing, monitoring and managing any type of primary brain tumour or brain metastases in people aged 16 or over. It aims to improve diagnosis and care, including standardising the care people have, how information and support are

Improving care for people with MS: the potential of data and technology – Nuffield Trust

This report for the MS Society by the Nuffield Trust examines four key areas in the lives and care of people with MS where the potential of data and technology could be harnessed to make a significant difference: Helping people

Clinical Commissioning Policy: Everolimus for refractory focal onset seizures associated with tuberous sclerosis complex (ages 2 years and above) – NHS England

This policy document outlines the arrangements for funding of treatment for refractory focal onset seizures, associated with tuberous sclerosis complex, for ages 2 years and above.

Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor: Interventional procedures guidance [IPG617] – NICE

Evidence-based recommendations on unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor in adults. This involves applying ultrasound to a specific area on 1 side of the brain (thalamus). The evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for

Beta interferons and glatiramer acetate for treating multiple sclerosis: Technology appraisal guidance [TA527] – NICE

Evidence-based recommendations on beta interferons (Avonex, Betaferon, Extavia, Rebif) and glatiramer acetate (Copaxone) for treating multiple sclerosis in adults. This guidance replaces NICE technology appraisal guidance 32 on beta interferon and glatiramer acetate for the treatment of multiple sclerosis.

Creutzfeldt-Jakob disease: guidelines for social workers in England – Department of Health and Social Care

These guidelines aim to increase awareness and understanding of CJD and improve social care for people who are affected by it. The guidelines update the previous guidance published in 2003. They reflect the increasing rareness of the disease and the

Urgent Clinical Commissioning Policy Statement: Natalizumabinduced Progressive Multifocal Leukoencephalopathy in relation to Immune Reconstitution Inflammatory Syndrome in Multiple Sclerosis (all ages) – NHS England

The use of Maraviroc to treat Natalizumab-induced PML-IRIS in relation to RRMS currently has an evidence base limited to very small observational studies. This indication and treatment is currently seen as experimental. Based on limited evidence and the lack of

Deaths Associated with Neurological Conditions in England 2001 to 2014: Data briefing – Public Health England

Report that finds: there is an increasing proportion of neurological deaths: a 39% increase in neurological deaths compared to a 6% decrease in all-cause deaths since 2001. Two major factors are likely to be contributing to this; theimproving survival rates from

Deaths associated with neurological conditions in England 2001 to 2014: Data analysis report – Public Health England

This report is about people who have died with a neurological condition recorded on their death certificate in England during the period of 2001 to 2014. It investigates: the numbers and rates of deaths associated with neurological conditions and their recent

Service specification: Neurointerventional Services for Acute Ischaemic & Haemorrhagic Stroke – NHS England

This service specification covers the provision of interventional neuroradiology services and should be read alongside the Neurosciences Specialised Neurology Service Specification and Neurosurgery (Adult) Service Specification.